Quantcast

Daily Traders Edge

4 Reasons Pfizer Remains A Buy Today

September 19
01:06 2016

Pfizer may have lagged some of its bigger rivals over the past year, but that doesn’t mean that it isn’t a great long-term dividend growth stock. Find our 4 reasons why Wall Street is wrong for punishing Pfizer for its last two failed mega-mergers, and how you can benefit from the market’s short sightedness.

Continue Reading Here

Related Articles

Newsletter Signup

Sign up for our free newsletter